カワサキ病の診断と管理
1Division of Pediatric Cardiology, College of Physicians and Surgeons, Columbia University, New York, NY.
JAMA
|May 22, 1991
まとめ
川崎病は,子供に影響を与える急性血管炎です. アスピリンと静脈内ガンマグローブリンによる早期治療は,冠動脈動脈瘤と長期的な心臓合併症の予防に不可欠です.
科学分野:
- 小児科は小児科です.
- レウマトロジーの病理学
- 心臓病学 心臓病学
背景:
- 川崎病は,熱,発疹,炎症を含む特徴的な症状を持つ急性血管炎です.
- 心筋炎や冠動脈動脈瘤などの心臓の関与は大きな懸念事項です.
- 病因は不明で,感染源が疑われる.
研究 の 目的:
- カワサキ病の臨床表現,心臓への影響,および管理についてまとめます.
- 長期的なリスク,特に冠動脈異常を強調する.
- 注意深いフォローアップの必要性を強調し,川崎病を潜在的な冠動脈疾患のリスク因子として考慮する.
主な方法:
- カワサキ病の臨床的特徴と既知のアウトカムのレビュー.
- 早期および遅期の心臓症状の分析.
- 現在の治療戦略の評価と長期的な予後.
主要な成果:
- 早期の心臓への影響には,心筋炎と心周炎が含まれ,冠動脈動脈瘤は長期的なリスクです.
- 静脈内ガンマグローブリンとアスピリンは,動脈瘤を予防するための標準的な治療法です.
- 巨大動脈瘤は,閉塞性冠動脈疾患のリスクを高め,バイパス移植が必要になる可能性があります.
結論:
- 川崎病は,心臓のリスクを軽減するために迅速な管理を必要とします.
- 長期的なフォローアップは,特に冠動脈異常を有する患者のために不可欠です.
- カワサキ病の幼児期は,特に西洋人では,将来の冠動脈疾患の危険因子である可能性があります.
関連する概念動画
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...


